long half-life and large variability [Regulatives / Guidelines]

posted by martin  – Austria, 2020-07-29 16:57 (287 d 12:53 ago) – Posting: # 21798
Views: 2,023

Dear all,

I would appreciate the forum members thoughts on the following situation.

In short:My interpretation of regulatoy guidelines: adding additional fixed effect factors to the factors mentioned in the guidelines is typically considered as not acceptable by regulators.

best regards & looking forward to some ideas to potentially address this situation

martin

Complete thread:

Activity
 Admin contact
21,457 posts in 4,485 threads, 1,512 registered users;
online 15 (0 registered, 15 guests [including 2 identified bots]).
Forum time: Thursday 05:50 CEST (Europe/Vienna)

Nothing in the world is more dangerous
than sincere ignorance
and conscientious stupidity.    Martin Luther King, Jr.

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5